488 related articles for article (PubMed ID: 30507951)
1. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
3. Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets.
Kiseleva I; Krutikova E; Stepanova E; Donina S; Pisareva M; Krivitskaya V; Rekstin A; Sparrow EG; Torelli G; Rudenko L
Biomed Res Int; 2018; 2018():9695628. PubMed ID: 30246028
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
[TBL] [Abstract][Full Text] [Related]
5. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.
Kieninger D; Sheldon E; Lin WY; Yu CJ; Bayas JM; Gabor JJ; Esen M; Fernandez Roure JL; Narejos Perez S; Alvarez Sanchez C; Feng Y; Claeys C; Peeters M; Innis BL; Jain V
BMC Infect Dis; 2013 Jul; 13():343. PubMed ID: 23883186
[TBL] [Abstract][Full Text] [Related]
8. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
[TBL] [Abstract][Full Text] [Related]
9. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
Domachowske JB; Pankow-Culot H; Bautista M; Feng Y; Claeys C; Peeters M; Innis BL; Jain V
J Infect Dis; 2013 Jun; 207(12):1878-87. PubMed ID: 23470848
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
[TBL] [Abstract][Full Text] [Related]
12. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months.
Lee JH; Cho HK; Kim KH; Lee J; Kim YJ; Eun BW; Kim NH; Kim DH; Jo DS; Kim HM; Kim YK
J Korean Med Sci; 2019 Dec; 34(46):e279. PubMed ID: 31779056
[TBL] [Abstract][Full Text] [Related]
14. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.
Skowronski DM; Hamelin ME; Janjua NZ; De Serres G; Gardy JL; Rhéaume C; Bouhy X; Boivin G
PLoS One; 2012; 7(6):e38929. PubMed ID: 22745690
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
Shen Z; Bowen RA; Ge P; Yu J; Shen Y; Kong W; Jiang C; Wu J; Zhu C; Xu Y; Wei W; Rudenko L; Kiseleva I; Xu F
Vaccine; 2016 Nov; 34(48):5953-5958. PubMed ID: 27997342
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
[TBL] [Abstract][Full Text] [Related]
18. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
19. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.
Mohn KGI; Zhou F; Brokstad KA; Sridhar S; Cox RJ
J Infect Dis; 2017 May; 215(10):1527-1535. PubMed ID: 28368530
[TBL] [Abstract][Full Text] [Related]
20. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
